Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (451)
|
Core Tip (501)
|
Full Article (HTML) (1896)
|
Figures (1-1) (323)
|
Full Article (PDF)-1204K (128)
|
Full Article with Cover (PDF)-11949K (106)
|
Full Article (XML)-236K (72)
|
Audio-1342K (6)
|
Peer-Review Report-230K (71)
|
Answering Reviewers-97K (66)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5082)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (464)
|
Core Tip (519)
|
Full Article (HTML) (1270)
|
Tables (1-1) (403)
|
Full Article (PDF)-358K (108)
|
Full Article with Cover (PDF)-11106K (90)
|
Full Article (XML)-54K (60)
|
Audio-1072K (7)
|
Peer-Review Report-236K (57)
|
Answering Reviewers-62K (55)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4146)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (507)
|
Core Tip (429)
|
Full Article (HTML) (4350)
|
Figures (1-2) (351)
|
Tables (1-5) (329)
|
Full Article (PDF)-1655K (190)
|
Full Article with Cover (PDF)-12399K (145)
|
Full Article (XML)-226K (63)
|
Audio-1259K (8)
|
Peer-Review Report-216K (65)
|
Answering Reviewers-145K (60)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (7350)
|
Similar Articles (61)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (513)
|
Core Tip (447)
|
Full Article (HTML) (2998)
|
Figures (1-1) (350)
|
Full Article (PDF)-601K (213)
|
Full Article with Cover (PDF)-11346K (84)
|
Full Article (XML)-89K (72)
|
Audio-384K (5)
|
Peer-Review Report-180K (59)
|
Answering Reviewers-74K (66)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (5803)
|
Similar Articles (332)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (519)
|
Core Tip (458)
|
Article Highlights (481)
|
Full Article (HTML) (1911)
|
Figures (1-4) (330)
|
Tables (1-3) (311)
|
Full Article (PDF)-1672K (109)
|
Full Article with Cover (PDF)-12418K (105)
|
Full Article (XML)-173K (62)
|
Audio-467K (6)
|
Peer-Review Report-182K (55)
|
Answering Reviewers-71K (81)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5738)
|
Similar Articles (1981)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (492)
|
Core Tip (492)
|
Article Highlights (579)
|
Full Article (HTML) (1737)
|
Figures (1-3) (365)
|
Tables (1-2) (333)
|
Full Article (PDF)-1874K (103)
|
Full Article with Cover (PDF)-12619K (98)
|
Full Article (XML)-114K (60)
|
Audio-386K (9)
|
Peer-Review Report-233K (79)
|
Answering Reviewers-161K (69)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6473)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (415)
|
Core Tip (418)
|
Article Highlights (485)
|
Full Article (HTML) (1198)
|
Figures (1-4) (299)
|
Full Article (PDF)-5746K (101)
|
Full Article with Cover (PDF)-16492K (81)
|
Full Article (XML)-96K (67)
|
Audio-3997K (6)
|
Peer-Review Report-192K (59)
|
Answering Reviewers-146K (66)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4287)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (469)
|
Core Tip (449)
|
Article Highlights (491)
|
Full Article (HTML) (2162)
|
Figures (1-4) (289)
|
Tables (1-5) (322)
|
Full Article (PDF)-6006K (130)
|
Full Article with Cover (PDF)-16750K (99)
|
Full Article (XML)-200K (59)
|
Audio-376K (3)
|
Peer-Review Report-182K (64)
|
Answering Reviewers-60K (72)
|
Supplementary Material-355K (76)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6998)
|
Similar Articles (1833)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (428)
|
Core Tip (493)
|
Article Highlights (493)
|
Full Article (HTML) (1411)
|
Figures (1-4) (313)
|
Tables (1-4) (315)
|
Full Article (PDF)-5941K (102)
|
Full Article with Cover (PDF)-16687K (79)
|
Full Article (XML)-115K (60)
|
Audio-187K (9)
|
Peer-Review Report-215K (55)
|
Answering Reviewers-37K (66)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5672)
|
Similar Articles (2434)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (450)
|
Core Tip (454)
|
Full Article (HTML) (1134)
|
Figures (1-1) (378)
|
Full Article (PDF)-5068K (90)
|
Full Article with Cover (PDF)-15813K (75)
|
Full Article (XML)-63K (54)
|
Audio-811K (3)
|
Peer-Review Report-266K (65)
|
Answering Reviewers-225K (62)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4486)
|
Similar Articles (4176)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (438)
|
Core Tip (463)
|
Full Article (HTML) (1129)
|
Full Article (PDF)-325K (93)
|
Full Article with Cover (PDF)-11079K (74)
|
Full Article (XML)-24K (68)
|
Audio-243K (1)
|
Peer-Review Report-215K (50)
|
Answering Reviewers-19K (51)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3178)
|
Similar Articles (391)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open